Lutein and zeaxanthin

Alternative Medicine Review

Volumn 10, Issue 2, 2005, Pages 128-135

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOBESITY AGENT; ANTIOXIDANT; BETA CAROTENE; COLESTIPOL; COLESTYRAMINE; LANSOPRAZOLE; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR; RABEPRAZOLE; UNCLASSIFIED DRUG; XANTHOPHYLL; XENOCAL; ZEAXANTHIN; DRUG DERIVATIVE;

CARDIOVASCULAR DISEASE; CATARACT; CLINICAL TRIAL; DIETARY INTAKE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG MECHANISM; DRUG TRANSPORT; HUMAN; LUNG CANCER; RETINA MACULA AGE RELATED DEGENERATION; RETINITIS PIGMENTOSA; REVIEW; STEREOISOMERISM; STROKE; TREATMENT INDICATION; ULTRAVIOLET RADIATION; VITAMIN SUPPLEMENTATION; ARTICLE; CHEMISTRY; LUNG TUMOR; RADIATION DERMATITIS; RETINA MACULA DEGENERATION;

BETA CAROTENE; CARDIOVASCULAR DISEASES; CATARACT; HUMANS; LUNG NEOPLASMS; LUTEIN; MACULAR DEGENERATION; RADIODERMATITIS; RETINITIS PIGMENTOSA; XANTHOPHYLLS;

EID: 21344441465     PISSN: 10895159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (61)

1. Landrum JT, Bone RA. Lutein, zeaxanthin, and the macular pigment. Arch Biochem Biophys 2001;385:28-40.
2. Khachik F, Spangler CJ, Smith JC, et al. Identification, quantification, and relative concentrations of carotenoids and their metabolites in human milk and serum. Anal Chem 1997;69:1873-1881.
3. Sommerburg O, Keunen JE, Bird AC, van Kuijk FJ. Fruits and vegetables that are sources for lutein and zeaxanthin: the macular pigment in human eyes. Br J Ophthalmol 1998;82:907-910.
4. Age-Related Macular Degeneration Foundation website: www.macular.org/ nutrition/zeaxan.html
5. Johnson EJ. The role of carotenoids in human health. Nutr Clin Care 2002;5:56-65.
6. Bone RA, Landrum JT, Fernandez L, Tarsis SL. Analysis of the macular pigment by HPLC: retinal distribution and age study. Invest Ophthalmol Vis Sci 1988;29:843-849.
7. Castenmiller JJ, West CE, Linssen JP, et al. The food matrix of spinach is a limiting factor in determining the bioavailability of beta-carotene and to a lesser extent of lutein in humans. J Nutr 1999;129:349-355.
8. Yeum KJ, Russell RM. Carotenoid bioavailability and bioconversion. Annu Rev Nutr 2002;22:483-504.
9. O'Neill ME, Thurnham DI. Intestinal absorption of beta-carotene, lycopene and lutein in men and women following a standard meal: response curves in the triacylglycerol-rich lipoprotein fraction. Br J Nutr 1998;79:149-159.
10. Kostic D, White WS, Olson JA. Intestinal absorption, serum clearance, and interactions between lutein and beta-carotene when administered to human adults in separate or combined oral doses. Am J Clin Nutr 1995;62:604-610.
11. Albanes D, Virtamo J, Taylor PR, et al. Effects of supplemental beta-carotene, cigarette smoking, and alcohol consumption on serum carotenoids in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Am J Clin Nutr 1997;66:336-372.
12. Alberg A. The influence of cigarette smoking on circulating concentrations of antioxidant micronutrients. Toxicology 2002;180:121-137.
13. Brady WE, Mares-Perlman JA, Bowen P, Stacewicz-Sapuntzakis M. Human serum carotenoid concentrations are related to physiologic and lifestyle factors. J Nutr 1996;126:129-137.
14. Williams AW, Boileau TW, Erdman JW Jr. Factors influencing the uptake and absorption of carotenoids. Proc Soc Exp Biol Med 1998;218:106-108.
15. Kritchevsky SB. Beta-carotene, carotenoids and the prevention of coronary heart disease. J Nutr 1999;129:5-8.
16. Street DA, Comstock GW, Salkeld R, et al. Serum antioxidants and myocardial infarction. Are low levels of carotenoids and alpha-tocopherol risk factors for myocardial infarction? Circulation 1994;90:1154-1161.
17. Connor SL, Ojeda LS, Sexton G, et al. Diets lower in folic acid and carotenoids are associated with the coronary disease epidemic in Central and Eastern Europe. J Am Diet Assoc 2004;104:1793-1799.
18. Ascherio A, Rimm EB, Hernan MA, et al. Relation of consumption of vitamin E, vitamin C, and carotenoids to risk for stroke among men in the United States. Ann Intern Med 1999;130:963-970.
19. Hirvonen T, Virtamo I, Korhonen P, et al. Intake of flavonoids, carotenoids, vitamin C and E, and risk of stroke in male smokers. Stroke 2000;31:2301-2306.
20. Holick CN, Michaud DS, Stolzenberg-Solomon R, et al. Dietary carotenoids, serum beta-carotene, and retinol and risk of lung cancer in the Alpha-Tocopherol, Beta-Carotene cohort study. Am J Epidemiol 2002;156:536-547.
21. Voorrips LE, Goldbohm RA, Brants HA, et al. A prospective cohort study on antioxidant and folate intake and male lung cancer risk. Cancer Epidemiol Biomarkers Prev 2000;9:357-365.
22. Martin KR, Wu D, Meydani M. The effect of carotenoids on the expression of cell surface adhesion molecules and binding of monocytes to human aortic endothelial cells. Atherosclerosis 2000;150:265-274.
23. Dwyer JH, Navab M, Dwyer KM, et al. Oxygenated carotenoid lutein and progression of early atherosclerosis; the Los Angeles Artherosclerosis Study. Circulation 2001;103:2922-2927.
24. Ribaya-Mercado JD, Garmyn M, Gilchrest BA, Russell RM. Skin lycopene is destroyed preferentially over beta-carotene during ultraviolet irradiation in humans. J Nutr 1995;125:1854-1859.
25. Sorg O, Tran C, Carraux P, et al. Oxidative stress-independent depletion of epidermal vitamin A by UVA. J Invest Dermatol 2002;118:513-518.
26. Stahl W, Sies H. Carotenoids and protection against solar UV radiation. Skin Pharmacol Appl Skin Physiol 2002;15:291-296.
27. Beatty S, Koh H, Phil M, et al. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 2000;45:115-134.
28. th ed. Rahway, NJ: Merck & Co., Inc; 1987.
29. Seddon JM, Ajani UA, Sperduto RD, et al. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group. JAMA 1994;272:1413-1420.
30. Curran-Celentano J, Hammond BR Jr, Ciulla TA, et al. Relation between dietary intake, serum concentrations, and retinal concentrations of lutein and zeaxanthin in adults in a midwest population. Am J Clin Nutr 2001;74:796-802.
31. Bernstein PS, Zhao DY, Wintch SW, et al. Resonance Raman measurement of macular carotenoids in normal subjects and in age-related macular degeneration patients. Ophthalmology 2002;109:1780-1787.
32. Richer S. ARMD-pilot (case series) environmental intervention data. J Am Optom Assoc 1999;70:24-36.
33. Richer S, Stiles W, Statkute L, et al. Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study. (Lutein Antioxidant Supplementation Trial). Optometry 2004;75:216-230.
34. Massacesi AL, Faletra R, Gerosa F, et al. The effect of oral supplementation of macular carotenoids (lutein and zeaxanthin) on the prevention of age-related macular degeneration: 18 months of follow up study. Assoc Res Vision Ophthalmol 2001;42: S234.
35. Horton J. Disorders of the eye. In: Fauci AS, Braunwald E, Isselbacher KJ, et al, eds. Harrison's Principles of Internal Medicine. 14th ed. New York, NY: McGraw-Hill; 1998:168.
36. Spector A, Garner WH. Hydrogen peroxide and human cataract. Exp Eye Res 1981;33:673-681.
37. Yeum KJ, Shang FM, Schalch WM, et al. Fat-soluble nutrient concentrations in different layers of human cataractous lens. Curr Eye Res 1999;19:502-505.
38. Chasen-Taber L, Willett WC, Seddon JM, et al. A prospective study of carotenoid and vitamin A intakes and risk of cataract extraction in U.S. women. Am J Clin Nutr 1999;70:509-516.
39. Brown L, Rimm EB, Seddon JM, et al. A prospective study of carotenoid intake and risk of cataract extraction in U.S. men. Am J Clin Nutr 1999;70:517-524.
40. Tavani A, Negri E, La Vecchia C. Food and nutrient intake and risk of cataract. Ann Epidemiol 1996;6:41-46.
41. Olmedilla B, Granado F, Blanco I, Vaquero M. Lutein, but not alpha-tocopherol, supplementation improves visual function in patients with age-related cataracts: a 2-y double-blind, placebo-controlled pilot study. Nutrition 2003;19:21-24.
42. Berson EL. Nutrition and retinal degenerations. Int Ophthalmol Clin 2000;40:93-111.
43. Dagnelie G, Zorge IS, McDonald TM. Lutein improves visual function in some patients with retinal degeneration: a pilot study via the Internet. Optometry 2000;71:147-164.
44. Heinrich U, Gartner C, Wiebusch M, et al. Supplementation with beta-carotene or a similar amount of mixed carotenoids protects humans from UV-induced erythema. J Nutr 2003;133:98-101.
45. Wingerath T, Sies H, Stahl W. Xanthophyll esters in human skin. Arch Biochem Biophys 1998;355:271-274.
46. Khachik F, Beecher GR, Smith JC Jr. Lutein, lycopene, and their oxidative metabolites in chemoprevention of cancer. J Cell Biochem Suppl 1995;22:S236-S246.
47. Peng YM, Peng YS, Lin Y, et al. Concentrations and plasma-tissue-diet relationships of carotenoids, retinoids, and tocopherols in humans. Nutr Cancer 1995;23:233-246.
48. Gaziano JM, Manson JE, Branch LG, et al. A prospective study of consumption of carotenoids in fruits and vegetables and decreased cardiovascular mortality in the elderly. Ann Epidemiol 1995;5:255-260.
49. Krieglstein CF, Granger DN. Adhesion molecules and their role in vascular disease. Am J Hypertens 2001;14:44S-54S.
50. Iribarren C, Folsom AR, Jacobs DR Jr, et al. Association of serum vitamin levels, LDL susceptibility to oxidation, and autoantibodies against MDA-LDL with carotid atherosclerosis. A case-control study. The ARIC Study Investigators. Atherosclerosis Risk in Communities. Arterioscler Thromb Vasc Biol 1997;17:1171-1177.
51. Dwyer JH, Paul-Labrador MJ, Fan J, et al. Progression of carotid intima-media thickness and plasma antioxidants: the Los Angeles Atherosclerosis Study. Arterioscler Thromb Vasc Biol 2004;24:313-319.
52. Michaud DS, Feskanich D, Rimm EB, et al. Intake of specific carotenoids and risk of lung cancer in 2 prospective U.S. cohorts. Am J Clin Nutr 2000;72:990-997.
53. Le Marchand L, Hankin JH, Bach F, et al. An ecological study of diet and lung cancer in the South Pacific. Int J Cancer 1995;63:18-23.
54. van den Berg H. Effect of lutein on beta-carotene absorption and cleavage. Int J Vitam Nutr Res 1998;68:360-365.
55. Hendler SS, Rorvik DR, eds. PDR for Nutritional Supplements. Montvale, NJ: Medical Economics Company, Inc.; 2001.
56. Tang G, Serfaty-Lacrosniere C, Camilo ME, Russell RM. Gastric acidity influences the blood response to a beta-carotene dose in humans. Am J Clin Nutr 1996;64:622-626.
57. Granado F, Olmedilla B, Gil-Martinez E, Blanco I. Lutein ester in serum after lutein supplementation in human subjects. Br J Nutr 1998;80:445-449.
58. Gonzalez de Mejia E, Ramos-Gomez M, Loarca-Pina G. Antimutagenic activity of natural xanthophylls against aflatoxin B1 in Salmonella typhimurium. Environ Mol Mutagen 1997;30:346-353.
59. Food and Nutrition Board, Institute of Medicine. Appendix C: Dietary intake data from the Third National Health and Nutrition Examination Survey (NHANES III), 1988-1994. Washington DC: National Academy Press; 2001:594-605.
60. Bowen PE, Herbst-Espinosa SM, Hussain EA, et al. Esterification does not impair lutein bioavailability in humans. J Nutr 2002;132:3668-3673.
61. van Het Hof KH, West CE, Weststrate JA, Hautvast JG. Dietary factors that affect the bioavailability of carotenoids. J Nutr 2000;130:503-506.